Yamanouchi Pharmaceutical Co. v. Danbury Pharmacal, Inc.

MEMORANDUM AND ORDER

OWEN, District Judge.

I presided over the trial here that lasted four days in April 1998. I found that the defendants willfully infringed the plaintiffs’ patent for famotidine in violation of the Hatch-Waxman Act, Yamanouchi Pharmaceutical Co. v. Danbury Pharmacal, Inc., 21 F.Supp.2d 366, 378 (S.D.N.Y.1998), familiarity with which is assumed. I found that this case constituted an “exceptional case” within the meaning of Section 285, and on that basis awarded attorneys’ fees to the plaintiffs, in an amount to be determined. The parties have since submitted post-trial…